United States Opthalmic Therapeutics Market Report 2017

United States Opthalmic Therapeutics Market Report 2017

1 Opthalmic Therapeutics Overview

1.1 Product Overview and Scope of Opthalmic Therapeutics

1.2 Classification of Opthalmic Therapeutics

1.2.1 Type I

1.2.2 Type II

1.3 Application of Opthalmic Therapeutics

1.3.1 Application 1

1.3.2 Application 2

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Opthalmic Therapeutics (2012-2022)

1.4.1 United States Opthalmic Therapeutics Sales and Growth Rate (2012-2022)

1.4.2 United States Opthalmic Therapeutics Revenue and Growth Rate (2012-2022)

2 United States Opthalmic Therapeutics Competition by Manufacturers

2.1 United States Opthalmic Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Opthalmic Therapeutics Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Opthalmic Therapeutics Average Price by Manufactures (2015 and 2016)

2.4 Opthalmic Therapeutics Market Competitive Situation and Trends

2.4.1 Opthalmic Therapeutics Market Concentration Rate

2.4.2 Opthalmic Therapeutics Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Opthalmic Therapeutics Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Opthalmic Therapeutics Sales and Market Share by States (2012-2017)

3.2 United States Opthalmic Therapeutics Revenue and Market Share by States (2012-2017)

3.3 United States Opthalmic Therapeutics Price by States (2012-2017)

4 United States Opthalmic Therapeutics Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Opthalmic Therapeutics Sales and Market Share by Type (2012-2017)

4.2 United States Opthalmic Therapeutics Revenue and Market Share by Type (2012-2017)

4.3 United States Opthalmic Therapeutics Price by Type (2012-2017)

4.4 United States Opthalmic Therapeutics Sales Growth Rate by Type (2012-2017)

5 United States Opthalmic Therapeutics Sales (Volume) by Application (2012-2017)

5.1 United States Opthalmic Therapeutics Sales and Market Share by Application (2012-2017)

5.2 United States Opthalmic Therapeutics Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Opthalmic Therapeutics Manufacturers Profiles/Analysis

6.1 Actavis

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Opthalmic Therapeutics Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Actavis Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Bayer

6.2.2 Opthalmic Therapeutics Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Bayer Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 F. Hoffmann-La Roche

6.3.2 Opthalmic Therapeutics Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 F. Hoffmann-La Roche Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Merck

6.4.2 Opthalmic Therapeutics Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Merck Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Novartis

6.5.2 Opthalmic Therapeutics Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Novartis Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Pfizer

6.6.2 Opthalmic Therapeutics Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Pfizer Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Regeneron Pharmaceuticals

6.7.2 Opthalmic Therapeutics Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Regeneron Pharmaceuticals Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Acadia Pharmaceuticals

6.8.2 Opthalmic Therapeutics Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Acadia Pharmaceuticals Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Alcon

6.9.2 Opthalmic Therapeutics Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Alcon Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Allergan

6.10.2 Opthalmic Therapeutics Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Allergan Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Boehringer Ingelheim

6.12 Falcon Pharmaceuticals

6.13 GlaxoSmithKline

6.14 Lexicon Pharmaceuticals

6.15 OPKO Health

6.16 Otsuka Pharmaceutical

6.17 R-Tech Ueno

6.18 Senju Pharmaceutical

6.19 Valeant Pharmaceuticals

7 Opthalmic Therapeutics Manufacturing Cost Analysis

7.1 Opthalmic Therapeutics Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Opthalmic Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Opthalmic Therapeutics Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Opthalmic Therapeutics Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Opthalmic Therapeutics Market Forecast (2017-2022)

11.1 United States Opthalmic Therapeutics Sales, Revenue Forecast (2017-2022)

11.2 United States Opthalmic Therapeutics Sales Forecast by Type (2017-2022)

11.3 United States Opthalmic Therapeutics Sales Forecast by Application (2017-2022)

11.4 Opthalmic Therapeutics Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Opthalmic Therapeutics

Table Classification of Opthalmic Therapeutics

Figure United States Sales Market Share of Opthalmic Therapeutics by Type in 2015

Table Application of Opthalmic Therapeutics

Figure United States Sales Market Share of Opthalmic Therapeutics by Application in 2015

Figure United States Opthalmic Therapeutics Sales and Growth Rate (2012-2022)

Figure United States Opthalmic Therapeutics Revenue and Growth Rate (2012-2022)

Table United States Opthalmic Therapeutics Sales of Key Manufacturers (2015 and 2016)

Table United States Opthalmic Therapeutics Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Opthalmic Therapeutics Sales Share by Manufacturers

Figure 2016 Opthalmic Therapeutics Sales Share by Manufacturers

Table United States Opthalmic Therapeutics Revenue by Manufacturers (2015 and 2016)

Table United States Opthalmic Therapeutics Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Opthalmic Therapeutics Revenue Share by Manufacturers

Table 2016 United States Opthalmic Therapeutics Revenue Share by Manufacturers

Table United States Market Opthalmic Therapeutics Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Opthalmic Therapeutics Average Price of Key Manufacturers in 2015

Figure Opthalmic Therapeutics Market Share of Top 3 Manufacturers

Figure Opthalmic Therapeutics Market Share of Top 5 Manufacturers

Table United States Opthalmic Therapeutics Sales by States (2012-2017)

Table United States Opthalmic Therapeutics Sales Share by States (2012-2017)

Figure United States Opthalmic Therapeutics Sales Market Share by States in 2015

Table United States Opthalmic Therapeutics Revenue and Market Share by States (2012-2017)

Table United States Opthalmic Therapeutics Revenue Share by States (2012-2017)

Figure Revenue Market Share of Opthalmic Therapeutics by States (2012-2017)

Table United States Opthalmic Therapeutics Price by States (2012-2017)

Table United States Opthalmic Therapeutics Sales by Type (2012-2017)

Table United States Opthalmic Therapeutics Sales Share by Type (2012-2017)

Figure United States Opthalmic Therapeutics Sales Market Share by Type in 2015

Table United States Opthalmic Therapeutics Revenue and Market Share by Type (2012-2017)

Table United States Opthalmic Therapeutics Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Opthalmic Therapeutics by Type (2012-2017)

Table United States Opthalmic Therapeutics Price by Type (2012-2017)

Figure United States Opthalmic Therapeutics Sales Growth Rate by Type (2012-2017)

Table United States Opthalmic Therapeutics Sales by Application (2012-2017)

Table United States Opthalmic Therapeutics Sales Market Share by Application (2012-2017)

Figure United States Opthalmic Therapeutics Sales Market Share by Application in 2015

Table United States Opthalmic Therapeutics Sales Growth Rate by Application (2012-2017)

Figure United States Opthalmic Therapeutics Sales Growth Rate by Application (2012-2017)

Table Actavis Basic Information List

Table Actavis Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Actavis Opthalmic Therapeutics Sales Market Share (2012-2017)

Table Bayer Basic Information List

Table Bayer Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bayer Opthalmic Therapeutics Sales Market Share (2012-2017)

Table F. Hoffmann-La Roche Basic Information List

Table F. Hoffmann-La Roche Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table F. Hoffmann-La Roche Opthalmic Therapeutics Sales Market Share (2012-2017)

Table Merck Basic Information List

Table Merck Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Merck Opthalmic Therapeutics Sales Market Share (2012-2017)

Table Novartis Basic Information List

Table Novartis Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis Opthalmic Therapeutics Sales Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Pfizer Opthalmic Therapeutics Sales Market Share (2012-2017)

Table Regeneron Pharmaceuticals Basic Information List

Table Regeneron Pharmaceuticals Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Regeneron Pharmaceuticals Opthalmic Therapeutics Sales Market Share (2012-2017)

Table Acadia Pharmaceuticals Basic Information List

Table Acadia Pharmaceuticals Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Acadia Pharmaceuticals Opthalmic Therapeutics Sales Market Share (2012-2017)

Table Alcon Basic Information List

Table Alcon Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Alcon Opthalmic Therapeutics Sales Market Share (2012-2017)

Table Allergan Basic Information List

Table Allergan Opthalmic Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Allergan Opthalmic Therapeutics Sales Market Share (2012-2017)

Table Boehringer Ingelheim Basic Information List

Table Falcon Pharmaceuticals Basic Information List

Table GlaxoSmithKline Basic Information List

Table Lexicon Pharmaceuticals Basic Information List

Table OPKO Health Basic Information List

Table Otsuka Pharmaceutical Basic Information List

Table R-Tech Ueno Basic Information List

Table Senju Pharmaceutical Basic Information List

Table Valeant Pharmaceuticals Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Opthalmic Therapeutics

Figure Manufacturing Process Analysis of Opthalmic Therapeutics

Figure Opthalmic Therapeutics Industrial Chain Analysis

Table Raw Materials Sources of Opthalmic Therapeutics Major Manufacturers in 2015

Table Major Buyers of Opthalmic Therapeutics

Table Distributors/Traders List

Figure United States Opthalmic Therapeutics Production and Growth Rate Forecast (2017-2022)

Figure United States Opthalmic Therapeutics Revenue and Growth Rate Forecast (2017-2022)

Table United States Opthalmic Therapeutics Production Forecast by Type (2017-2022)

Table United States Opthalmic Therapeutics Consumption Forecast by Application (2017-2022)

Table United States Opthalmic Therapeutics Sales Forecast by States (2017-2022)

Table United States Opthalmic Therapeutics Sales Share Forecast by States (2017-2022)